Where Will Palo Alto Networks Stock Be in 5 Years?
You know those companies that just refuse to slow down…
Buy
58
NUTX Quote, Financials, Valuation and Earnings
Last price:
$163.80
Seasonality move
:
4242.83%
Day range:
$156.53 - $162.89
52-week range:
$4.16 - $184.28
Dividend yield:
0%
P/E ratio:
13.45x
P/S ratio:
1.44x
P/B ratio:
4.52x
Volume:
66.5K
Avg. volume:
158.9K
1-year change:
2061.49%
Market cap:
$890.2M
Revenue:
$479.9M
EPS (TTM):
$11.89
Analysts' Opinion
-
Consensus RatingNutex Health has received a consensus rating of Buy. The company's average rating is a Buy based on 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $248.33, Nutex Health has an estimated upside of 55.26% from its current price of $159.95.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $220.00 representing -- downside risk from its current price of $159.95.
Fair Value
-
According to the consensus of 2 analysts, Nutex Health has 55.26% upside to fair value with a price target of $248.33 per share.
NUTX vs. S&P 500
-
Over the past 5 trading days, Nutex Health has overperformed the S&P 500 by 2.68% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Nutex Health does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Nutex Health has grown year-over-year revenues for 8 quarters straight. In the most recent quarter Nutex Health reported revenues of $211.8M.
Earnings Growth
-
Nutex Health has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Nutex Health reported earnings per share of $2.56.
Enterprise value:
925.8M
EV / Invested capital:
0.00x
Price / LTM sales:
1.44x
EV / EBIT:
4.77x
EV / Revenue:
1.48x
PEG ratio (5yr expected):
--
EV / Free cash flow:
13.33x
Price / Operating cash flow:
12.92x
Enterprise value / EBITDA:
4.32x
Gross Profit (TTM):
$304.4M
Return On Assets:
12.52%
Net Income Margin (TTM):
10.76%
Return On Equity:
46.74%
Return On Invested Capital:
36.5%
Operating Margin:
34.1%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $196.5M | $258.8M | $624.3M | $67.5M | $211.8M | |
| Gross Profit | -$15.5M | $40.1M | $304.4M | $10.2M | $118.3M | |
| Operating Income | -$38.3M | $4.4M | $208.5M | $1.5M | $72.2M | |
| EBITDA | -$424M | -$5.4M | $214.2M | $8.5M | $74M | |
| Diluted EPS | -$101.70 | -$9.62 | $11.89 | -$0.08 | $2.56 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $15M | $88.7M | $100.4M | $401.5M | |
| Total Assets | -- | $83.3M | $430.1M | $404.3M | $761.9M | |
| Current Liabilities | -- | $8.4M | $47.9M | $59.9M | $176.6M | |
| Total Liabilities | -- | $11.2M | $320.6M | $324.3M | $487M | |
| Total Equity | -- | $72.1M | $109.5M | $80M | $274.9M | |
| Total Debt | -- | $4.5M | $38.2M | $38.5M | $42.5M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $15.9M | $3.3M | $71.1M | $3.1M | $51M | |
| Cash From Investing | -$1.2M | -$6.6M | -$2M | -$733K | -$64K | |
| Cash From Financing | -$17.5M | $470.8K | -$11.4M | $5.7M | -$6.8M | |
| Free Cash Flow | $5.5M | -$2.6M | $69.4M | $2.3M | $50.9M | |
NUTX
Sector
Market Cap
$890.2M
$34.7M
Price % of 52-Week High
--
42.33%
Dividend Yield
0%
0%
Shareholder Yield
-0.15%
-0.66%
1-Year Price Total Return
2061.49%
-41.18%
Beta (5-Year)
-0.096
0.653
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
19.83%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$168.94
200-day SMA
Buy
Level
$51.75
Bollinger Bands (100)
Buy
Level
34.84 - 121.88
Chaikin Money Flow
Buy
Level
951.1K
20-day SMA
Buy
Level
$139.52
Relative Strength Index (RSI14)
Buy
Level
62.16
ADX Line
Buy
Level
33.49
Williams %R
Neutral
Level
-33.7965
50-day SMA
Buy
Level
$110.08
MACD (12, 26)
Buy
Level
16.40
25-day Aroon Oscillator
Buy
Level
52
On Balance Volume
Neutral
Level
4.6M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.1317)
Sell
CA Score
(Annual)
Level (-0.3877)
Sell
Beneish M-Score
(Annual)
Level (-0.7836)
Buy
Momentum Score
Level (10)
Buy
Ohlson Score
Level (-0.0343)
Buy
Piotroski F Score
(Annual)
Level (8)
Sell
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.
Stock Forecast FAQ
In the current month, NUTX has received 2 Buy ratings 0 Hold ratings, and 0 Sell ratings. The NUTX average analyst price target in the past 3 months is $248.33.
-
Where Will Nutex Health Stock Be In 1 Year?
According to analysts, the consensus estimate is that Nutex Health share price will rise to $248.33 per share over the next 12 months.
-
What Do Analysts Say About Nutex Health?
Analysts are divided on their view about Nutex Health share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Nutex Health is a Sell and believe this share price will drop from its current level to $220.00.
-
What Is Nutex Health's Price Target?
The price target for Nutex Health over the next 1-year time period is forecast to be $248.33 according to 2 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is NUTX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Nutex Health is a Buy. 2 of 2 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of NUTX?
You can purchase shares of Nutex Health via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Nutex Health shares.
-
What Is The Nutex Health Share Price Today?
Nutex Health was last trading at $163.80 per share. This represents the most recent stock quote for Nutex Health. Yesterday, Nutex Health closed at $159.95 per share.
-
How To Buy Nutex Health Stock Online?
In order to purchase Nutex Health stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
UPS Stock Forecast: Is the 6.9% Dividend Too Good to Be True?
Parcel delivery giant UPS (NYSE:UPS) has seen its fair share…
Where Will Coinbase Stock Be in 5 Years?
If you’ve been anywhere near the crypto world over the…
Stock Ideas
Buy
65
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 38x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 45x
Sell
33
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Alerts
Buy
55
SBET alert for May 27
SharpLink Gaming [SBET] is up 454.46% over the past day.
Buy
57
RGC alert for May 27
Regencell Bioscience Holdings [RGC] is down 9.77% over the past day.
Buy
90
OKLO alert for May 27
Oklo [OKLO] is up 10.05% over the past day.
